Stay updated on Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record describes a Phase 2 study of nivolumab maintenance therapy for high-risk aggressive B-cell lymphoma patients in complete remission, including its eligibility criteria, treatment plan, and study contacts in Israel.
    Difference
    45%
    Check dated 2026-11-08T02:24:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the study page remains inaccessible with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-31T22:28:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:26:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The revision label on the 403 error page changed from v3.7.1 to v3.7.2; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-17T22:26:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:22:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is shown instead of the study content, blocking access to the trial details. The rest of the site chrome remains visible.
    Difference
    18%
    Check dated 2026-09-19T20:50:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page.